Thierry Calandra
Impact in
- Immunology top 0.05%
- Macrophage Migration Inhibitory Factor
- Immune Response and Inflammation
Papers in
- Immunology 117
- Macrophage Migration Inhibitory Factor 72
- Immune Response and Inflammation 32
- Epidemiology 107
- Sepsis Diagnosis and Treatment 43
- Fungal Infections and Studies 28
- Co-authors
- Thierry Roger (64 shared papers)Jürgen Bernhagen (15 shared papers)M. P. Glauser (28 shared papers)Richard Bucala (16 shared papers)Richard Bucala (10 shared papers)Oscar Marchetti (39 shared papers)Christine N. Metz (10 shared papers)Jonathan Cohen (5 shared papers)
- Journals
- Clinical Infectious Diseases (19 papers)Critical Care Medicine (11 papers)Critical Care (9 papers)The Journal of Infectious Diseases (9 papers)PLoS ONE (9 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Thierry Calandra
246 papers receiving 33.0k citations
Thierry Calandra's Hit Papers
Peers
Comparison fields: 5 of 163
- Immunology 12.8k
- Critical Care and Intensive Care Medicine 2.9k
- Applied Microbiology and Biotechnology 1.1k
- Infectious Diseases 8.3k
- Clinical Biochemistry 3.0k
Countries citing papers authored by Thierry Calandra
This map shows the geographic impact of Thierry Calandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Calandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Calandra more than expected).
Fields of papers citing papers by Thierry Calandra
This network shows the impact of papers produced by Thierry Calandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Calandra. The network helps show where Thierry Calandra may publish in the future.
Co-authors
The 25 scholars most cited alongside Thierry Calandra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 254 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2009 | 2325 |
| 2 | Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Hit paper breakdown → | 2004 | 2299 |
| 3 | Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Hit paper breakdown → | 2004 | 1972 |
| 4 | Macrophage migration inhibitory factor: a regulator of innate immunity Hit paper breakdown → | 2003 | 1429 |
| 5 | 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer Hit paper breakdown → | 2002 | 1426 |
| 6 | MIF as a glucocorticoid-induced modulator of cytokine production Hit paper breakdown → | 1995 | 969 |
| 7 | MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia Hit paper breakdown → | 1993 | 861 |
| 8 | The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. Hit paper breakdown → | 1994 | 860 |
| 9 | Sepsis: a roadmap for future research Hit paper breakdown → | 2015 | 714 |
| 10 | Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes Hit paper breakdown → | 2007 | 667 |
| 11 | The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit Hit paper breakdown → | 2005 | 623 |
| 12 | Protection from septic shock by neutralization of macrophage migration inhibitory factor Hit paper breakdown → | 2000 | 616 |
| 13 | An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Hit paper breakdown → | 1996 | 589 |
| 14 | 2000 | 493 | |
| 15 | 2001 | 492 | |
| 16 | ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients Hit paper breakdown → | 2016 | 432 |
| 17 | Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock Hit paper breakdown → | 1990 | 428 |
| 18 | Changes in the epidemiological landscape of invasive candidiasis Hit paper breakdown → | 2017 | 390 |
| 19 | 2004 | 383 | |
| 20 | 1991 | 358 |
About Thierry Calandra
Thierry Calandra is a scholar working on Immunology, Epidemiology, Infectious Diseases, Oncology and Clinical Biochemistry, having authored 254 papers that have together received 33.9k indexed citations. Recurring topics across this work include Macrophage Migration Inhibitory Factor (72 papers), Antifungal resistance and susceptibility (43 papers), Neutropenia and Cancer Infections (43 papers), Sepsis Diagnosis and Treatment (43 papers), Bacterial Identification and Susceptibility Testing (34 papers), Immune Response and Inflammation (32 papers), Fungal Infections and Studies (28 papers) and Nuclear Receptors and Signaling (23 papers). The work is most often cited by research in Immunology (12.8k citations), Critical Care and Intensive Care Medicine (2.9k citations), Applied Microbiology and Biotechnology (1.1k citations), Infectious Diseases (8.3k citations) and Clinical Biochemistry (3.0k citations). Thierry Calandra has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Thierry Roger, Jürgen Bernhagen, M. P. Glauser, Richard Bucala, Richard Bucala, Oscar Marchetti, Christine N. Metz, Jonathan Cohen, Jean‐Louis Vincent and Robert A. Mitchell. Their work appears in journals such as Clinical Infectious Diseases, Critical Care Medicine, Critical Care, The Journal of Infectious Diseases and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.